Impactful research estimates on smoking-related mortality in India project that the country will soon see more than one million smoking deaths annually. Even in a nation as densely populated as India, the sheer size of these numbers is alarming. For more on the specifics of this data, host Dr. Mark Nolan Hill welcomes Dr. Prabhat Jha, professor of health and development, and founding director of the Centre for Global Health Research at the University of Toronto, and lead author of this noteworthy research published in the New England Journal of Medicine on the current smoking epidemic in India. How did Dr. Jha and his team coordinate the collection of data across the vast Indian subcontinent?
A Million Annual Smoking-Related Deaths in India
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Impactful research estimates on smoking-related mortality in India project that the country will soon see more than one million smoking deaths annually. Even in a nation as densely populated as India, the sheer size of these numbers is alarming. For more on the specifics of this data, host Dr. Mark Nolan Hill welcomes Dr. Prabhat Jha, professor of health and development, and founding director of the Centre for Global Health Research at the University of Toronto, and lead author of this noteworthy research published in the New England Journal of Medicine on the current smoking epidemic in India. How did Dr. Jha and his team coordinate the collection of data across the vast Indian subcontinent?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credits
<p>Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
0.50 credits
<p>IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue</p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
Cardiology
FINE-HEART Pooled Analysis
<p><span data-teams="true">FINE-HEART Pooled Analysis</span></p>
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
<p>FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?